Podcasts about Ophthalmology

Andrew Huberman, Ph.D., is a neuroscientist and tenured professor in the Departments of Neurobiology and Ophthalmology at Stanford University School of Medicine, where he runs the Huberman Lab. He is the author of Protocols: An Operating Manual for the Human Body.This episode is brought to you by:ProLon science-backed Fasting Mimicking Diet that helps activate cellular renewal through fasting, while still eating nourishing mealsEight Sleep Pod Cover 5 sleeping solution for dynamic cooling and heatingMomentous high-quality creatine for cognitive and muscular supportHelix Sleep premium mattressesTimestamps:00:00:00 — Who is Dr. Andrew Huberman?00:02:03 — Dean Potter, The Dark Wizard, and the physics of raw energy.00:04:11 — Why competition destroys performance.00:05:45 — Laird Hamilton, tow-in surfing, and the lure of big waves.00:06:27 — Training with Dorian Yates.00:18:29 — The full weekly split that keeps building strength at 50.00:21:00 — Neck training.00:25:56 — AssaultBike vs. Airdyne.00:31:12 — Revisiting MDMA and psychedelics.00:48:06 — Inducing plasticity is only half the job.00:53:17 — The one-day protocol that cut my anxiety by 90%.01:00:27 — Cortisol as the master key.01:03:26 — Peptides demystified: GLP-1s, growth hormone, and BPC-157.01:14:44 — The Enhanced Games, the Deca burrito, and the honesty problem.01:17:56 — Pinealon, epitalon, and the hunt for more REM sleep.01:25:02 — Why women, not gym bros, are the real peptide market.01:35:52 — Why "no reported side effects" is a trap.01:43:48 — Stem cells, cartilage regrowth, and mining the body for medicine.01:46:37 — AI, wearables, and the race to write to the nervous system.01:54:12 — The MIT mask that puts you to sleep in six minutes.01:56:09 — Inside Andrew's new operating manual, Protocols.02:03:30 — Navigating grief and remapping loss.02:04:40 — Shut up, suit up, show up.02:08:03 — Parting thoughts.*For show notes and past guests on The Tim Ferriss Show, please visit tim.blog/podcast.For deals from sponsors of The Tim Ferriss Show, please visit tim.blog/podcast-sponsorsSign up for Tim's email newsletter (5-Bullet Friday) at tim.blog/friday.For transcripts of episodes, go to tim.blog/transcripts.Discover Tim's books: tim.blog/books.Follow Tim:Twitter: twitter.com/tferriss Instagram: instagram.com/timferrissYouTube: youtube.com/timferrissFacebook: facebook.com/timferriss LinkedIn: linkedin.com/in/timferrissSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

I almost finished my July 4th call week. Good news! Portland did not blow its face off this year. No open globes, no eyelid lacerations, no thermal injuries, no sclopetaria. Bad news: a Friday holiday means every unanswered call from every patient at every one of our offices lands on the on-call doctor, and I earned every one of them. I walk through three cases. First, a cataract surgery my partner had to abort mid-procedure because the patient had six clock hours of zonule laxity. I explain what zonules actually do, why pseudoexfoliation ruins your day, and how a viscoelastic-driven pressure spike at 1 AM sent me to clinic to "burp the wound" instead of shipping the patient to the ED. Second, an inpatient consult for suspected optic disc swelling, and why nobody outside ophthalmology reliably examines an optic nerve. Third, the classic infectious disease vs. ophthalmology debate: does every asymptomatic patient with candidemia need a dilated eye exam? IDSA 2016 says yes. The American Academy of Ophthalmology says no. I'll tell you where I actually land and why I still show up anyway. Also: my full case for licensing fireworks rather than banning them, and a little pushback on the once-a-year concern for veterans and dogs. Live shows coming up in Boston and at the Lebanon Opera House in September. Takeaways: Zonule laxity, loose or broken suspensory fibers that hold the natural lens in place, can force a cataract surgeon to abort mid-procedure and refer to a retina specialist for a safer staged approach; pseudoexfoliation is one of the most common causes The viscoelastic gels used during cataract surgery can plug the eye's drainage system and cause an IOP spike that lasts up to 72 hours; oral Diamox is standard, but if the patient can't keep it down, options are IV Diamox in the ED or manually burping the wound in clinic Ophthalmologists are effectively the only clinicians reliably trained and equipped to examine the optic nerve, which is why hospitalist consults for suspected disc swelling should be treated as a normal part of the job, not an imposition The IDSA (2016) recommends dilated exams for all non-neutropenic candidemia patients within one week of diagnosis; the American Academy of Ophthalmology recommends against routine screening in asymptomatic patients. Practical approach for 2026: consult ophthalmology for any candidemia patient with visual symptoms (floaters, blurriness, pain, flashes) or who can't reliably report symptoms (intubated, delirious); asymptomatic reliable patients likely don't need routine screening To Get Tickets to Wife & Death: You can visit Glaucomflecken.com/live  We want to hear YOUR stories (and medical puns)! Shoot us an email and say hi! knockknockhi@human-content.com Can't get enough of us? Shucks. You can support the show on Patreon for early episode access, exclusive bonus shows, livestream hangouts, and much more! –⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ http://www.patreon.com/glaucomflecken⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠  Also, be sure to check out the newsletter: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://glaucomflecken.com/glauc-to-me/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ If you are interested in buying a book from one of our guests, check them all out here: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.amazon.com/shop/dr.glaucomflecken⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ If you want more information on models I use: Anatomy Warehouse provides for the best, crafting custom anatomical products, medical simulation kits and presentation models that create a lasting educational impact.  For more information go to Anatomy Warehouse DOT com. Link: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://anatomywarehouse.com/?aff=14⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Plus for 15% off use code: Glaucomflecken15 -- A friendly reminder from the G's and Tarsus: If you want to learn more about Demodex Blepharitis, making an appointment with your eye doctor for an eyelid exam can help you know for sure. Visit ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠http://www.EyelidCheck.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ for more information.  Produced by⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Human Content⁠ Learn more about your ad choices. Visit megaphone.fm/adchoices

Our guest is Dr Priscila Cruz Flores, an ophthalmologist from Mexico City who balances a private clinical practice with a strong dedication to surgical education and humanitarian work. She coordinates large-scale medical missions that provide free cataract surgeries to underserved rural communities throughout Mexico. Additionally, she co-founded EICCO, an international academic meeting designed to foster collaboration and education among ophthalmology residents and specialists. I was fortunate to join her at the last EICCO meeting (Encuentro Interinstitucional de Casos Clínicos en Oftalmología which means Inter-institutional Meeting of Clinical Cases in Ophthalmology) and was truly impressed with her passion and drive. So much to learn from this amazing colleague.We feature a new podcast every week on Sundays and they are uploaded to all major podcast services. The full video of the podcast is here on CataractCoach as well as on our YouTube channel. Starting now we have sponsorship opportunities available for the top podcast in all of ophthalmology. Please contact us to inquire.

A World Of Silence: Navigating Infant Hearing Loss & Cochlear Implants The ability to listen is the very first skill we develop in the womb, and it's crucial for cognitive growth. Thankfully, infants born with hearing loss have a few options to keep their development on track. Our experts this week explore the science of pediatric audiology, how to make an early diagnosis, and the cochlear implant journey. Guests:  Dr. Nancy Young, medical director of Audiology and Cochlear Implant Programs, The Ann & Robert H. Lurie Children's Hospital of Chicago, Lillian S. Wells professor in pediatric otolaryngology, Northwestern University Feinberg School of Medicine Eva Tweedy, parent Doug Tweedy, parent   Chronic Disease Is Threatening Your Vision – Here's How To Prevent It Millions of people are currently facing vision loss, and so many more are at risk due to a rise in chronic illnesses. Our experts reveal how common conditions like diabetes threaten our sight, and how proper management can stop this preventable damage in its tracks. Guests:  Jeff Todd, president & CEO, Prevent Blindness Dr. Paul Chan, chair, Department of Ophthalmology & Visual Sciences, University of Illinois Chicago, board member, Prevent Blindness   Facebook: ingoodhealthpodX: @ ingoodhealthpodIG: @ingoodhealthpodYouTube: @ingoodhealthpodSpotify Apple Podcast In Good Health PodcastSubscribed to the newsletterFull ArchiveContact UsBecome an Affiliate Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Chronic Disease Is Threatening Your Vision – Here's How To Prevent It Millions of people are currently facing vision loss, and so many more are at risk due to a rise in chronic illnesses. Our experts reveal how common conditions like diabetes threaten our sight, and how proper management can stop this preventable damage in its tracks. Guests:  Jeff Todd, president & CEO, Prevent Blindness Dr. Paul Chan, chair, Department of Ophthalmology & Visual Sciences, University of Illinois Chicago, board member, Prevent Blindness Host: Greg Johnson Producer: Kristen Farrah   Facebook: ingoodhealthpodX: @ ingoodhealthpodIG: @ingoodhealthpodYouTube: @ingoodhealthpodSpotify Apple Podcast In Good Health PodcastSubscribed to the newsletterFull ArchiveContact UsBecome an Affiliate Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Host Dr. Jay Sridhar welcomes Dr. Steven Gedde, the incoming CEO of the American Board of Ophthalmology (ABO), to discuss his outlook on medical education and the evolving board certification process. As medical knowledge now doubles approximately every 60 days, Dr. Gedde envisions the ABO shifting its focus from testing facts to assessing skills like communication, professionalism, and the use of technology. Although current surgical assessments focus on knowledge and decision-making, future evaluations may leverage AI and virtual reality to test technical competence.  For all episodes or to claim CME credit for selected episodes, visit www.aao.org/podcasts.  

Your eye color can change your day-to-day comfort in sunlight and it can hint at different long-term risks, but the real story is melanin. I'm Dr. Mark Grossman, an integrative medical optometrist and licensed acupuncturist, and I walk through what melanin is, how it functions as a natural pigment inside the eye, and why it acts like an internal shield against harmful light.We connect the science of eye pigment to practical outcomes: why darker eyes often block more UV and reduce internal glare, why lighter eyes can experience more light scatter and photophobia, and what that can mean for macular degeneration risk. We also discuss a noteworthy tradeoff mentioned by the American Academy of Ophthalmology about dark eyes and a slightly higher cataract risk, plus the higher risk of ocular uveal melanoma (a rare eye cancer) associated with lighter irises.From there, we get concrete about natural eye care and prevention. I explain melanin's protective roles like absorbing UVA and UVB radiation, helping stabilize free radicals, and filtering glare across the retina. Then we shift into what you can control today: wearing 100% UV-blocking sunglasses, using a wide-brimmed hat outdoors, and even looking into melanin-based sunglasses, which block 100% of UVA/UVB rays and filter High-Energy Visible (HEV) blue light. Finally, we review nutrients and herbs that may influence our ability to build melanin, including green tea, turmeric, ginseng, lotus flour, fenugreek, and saffron, with a clear-eyed look at what's promising versus what's not yet proven.If you care about eye health, UV protection, and simple habits that support healthy vision, subscribe, share this with a friend, and leave a review. And, visit us at https://naturaleyecare.com/

Drs. Kat Talcott and Akshay Thomas join for a journal club podcast discussion:‍‍Mark Cuban Cost Plus Ophthalmology Medications (https://www.aaojournal.org/article/S0161-6420(26)00378-7/fulltext)Resident Continuity Clinics (https://jamanetwork.com/journals/jamaophthalmology/article-abstract/2848897)PDR Long-Term Outcomes (https://www.ophthalmologyretina.org/article/S2468-6530(26)00218-6/abstract)Marginal Outer Retinal Ridge in PDR (https://www.ophthalmologyretina.org/article/S2468-6530(26)00274-5/abstract)‍ ‍

Wir springen in dieser Folge in die Mitte des 18. Jahrhunderts. Ein Augenarzt bereist in dieser Zeit nicht nur sein Heimatland England, sondern das gesamte vereinigte Königreich, schließlich auch den Kontintent und landet dann in Leipzig. Dort hat der berühmteste Musiker der Stadt, Johann Sebastian Bach, schon länger mit einem Augenleiden zu kämpfen, und der berühmte Augenarzt aus England wird ihn operieren. Nur, geht das auch gut aus? Wir sprechen in dieser Folge über Chevalier John Taylor, der in der Medizingeschichte manchmal als Pionier und oft als Quacksalber bezeichnet wurde, der aber tatsächlich eine Art Zwischenwelt in der Medizingeschichte bewohnte, in der die beiden Eigenschaften oft nicht so einfach voneinander zu trennen waren. // Erwähnte Folgen - GAG443: J.S. Bach oder Wie sich ein Komponist den Lebensunterhalt verdient – https://gadg.fm/443 - GAG546: Sarah Biffin, Miniaturmalerin – https://gadg.fm/546 // Literatur - Albert, Daniel M. / Paul Henkind, Men of Vision: Lives of Notable Figures in Ophthalmology, Philadelphia: W. B. Saunders, 1993. - Jackson, David M., „Bach, Handel, and the Chevalier Taylor“, in: Medical History 12/4 (1968), S. 385–393. - Lenth, Bert, „Bach and the English Oculist“, in: Music & Letters 19/2 (1938), S. 182–198. - Mounsey, Chris, Sight Correction: Vision and Blindness in Eighteenth-Century Britain, Charlottesville: University of Virginia Press, 2019. - Scholtz, Sibylle / Myriam Becker / Lee MacMorris / Achim Langenbucher, „Taylor. A Gold-Plated Charlatan“, in: Curiosities in Medicine: Alphabetically, Cham: Springer Nature Switzerland, 2025, S. 335–337. - Schwartz, Stephen G. / Christopher T. Leffler / Andrzej Grzybowski / Hans-Reinhard Koch / Dennis Bermudez, „The Taylor Dynasty: Three Generations of 18th–19th Century Oculists“, in: Historia Ophthalmologica Internationalis 1/1 (2015), S. 67–81. - Jones, Henry [zugeschrieben], The Life and Extraordinary History of the Chevalier John Taylor. Written from Authentic Materials, and Published by His Son, John Taylor, Oculist, Dublin: D. Chamberlain, 1761. - Zegers, Richard H. C., „The Eyes of Johann Sebastian Bach“, in: Archives of Ophthalmology 123/10 (2005), S. 1427–1430. Das Episodenbild zeigt John Taylor in der ersten Hälfte des 18. Jahrhunderts. Unser neues Buch „Mehr Geschichten aus der Geschichte“ erscheint am 4. September. Es kann hier signiert vorbestellt werden: https://shop.autorenwelt.de/products/mehr-geschichten-aus-der-geschichte-von-richard-hemmer-und-daniel-messner //Aus unserer Werbung Du möchtest mehr über unsere Werbepartner erfahren? Hier findest du alle Infos & Rabatte: https://linktr.ee/GeschichtenausderGeschichte //Geschichten aus der Geschichte jetzt auch als Brettspiel! Werkelt mit uns am Flickerlteppich! Gibt es dort, wo es auch Becher, T-Shirts oder Hoodies zu kaufen gibt: https://geschichte.shop // Wir sind jetzt auch bei CampfireFM! Wer direkt in Folgen kommentieren will, Zusatzmaterial und Blicke hinter die Kulissen sehen will: einfach die App installieren und unserer Community beitreten: https://www.joincampfire.fm/podcasts/22 Wer unsere Folgen lieber ohne Werbung anhören will, kann das über eine kleine Unterstützung auf Steady oder ein Abo des GeschichteFM-Plus Kanals auf Apple Podcasts tun. Wir freuen uns, wenn ihr den Podcast bei Apple Podcasts oder wo auch immer dies möglich ist rezensiert oder bewertet. Wir freuen uns auch immer, wenn ihr euren Freundinnen und Freunden, Kolleginnen und Kollegen oder sogar Nachbarinnen und Nachbarn von uns erzählt! Du möchtest Werbung in diesem Podcast schalten? Dann erfahre hier mehr über die Werbemöglichkeiten bei Seven.One Audio: https://www.seven.one/portfolio/sevenone-audio

Understanding how values and communication styles differ across cultures is key to succeeding internationally. That’s why training in cross-cultural communication has become commonplace in the international business world. In this session, we’ll look at 6 dimensions of cross-cultural communication and their application to medical scenarios.

Relebogile Mabotja speaks to Dr Precious Phatudi an Ophthalmologist about eye health and ophthalmology, unpacking everything about protecting your vision and maintaining healthy eyes. 702 Afternoons with Relebogile Mabotja is broadcast live on Johannesburg based talk radio station 702 every weekday afternoon. Relebogile brings a lighter touch to some of the issues of the day as well as a mix of lifestyle topics and a peak into the worlds of entertainment and leisure. Thank you for listening to a 702 Afternoons with Relebogile Mabotja podcast. Listen live on Primedia+ weekdays from 13:00 to 15:00 (SA Time) to Afternoons with Relebogile Mabotja broadcast on 702 https://buff.ly/gk3y0Kj For more from the show go to https://buff.ly/2qKsEfu or find all the catch-up podcasts here https://buff.ly/DTykncj Subscribe to the 702 Daily and Weekly Newsletters https://buff.ly/v5mfetc Follow us on social media: 702 on Facebook https://www.facebook.com/TalkRadio702 702 on TikTok: https://www.tiktok.com/@talkradio702 702 on Instagram: https://www.instagram.com/talkradio702/ 702 on X: https://x.com/Radio702 702 on YouTube: https://www.youtube.com/@radio702 See omnystudio.com/listener for privacy information.

Eye problems can stump even seasoned GPs, but they don't have to. On this episode of Vet Blast Podcast, host Adam Christman, DVM, MBA, sits down with veterinary ophthalmologist Kenneth Pierce, DVM, MS, DACVO, for a crash course in everyday ophthalmology. How do you tell cataracts from nuclear sclerosis in seconds? What's the smartest way to triage a corneal ulcer? And which red flags mean "emergency" the moment they walk through the door? Pierce breaks it all down with practical, step-by-step guidance you can use in clinic tomorrow.

In this episode, my guest is Dr. Glen Jeffery, PhD, a professor of neuroscience at University College London's Institute of Ophthalmology and a leading expert on how light interacts with mitochondria to shape health and aging. Today, he discusses how red and near-infrared light penetrate deep into the body and improve mitochondrial function and overall health. We also discuss how detrimental modern indoor life has become and why expensive red light panels are likely unnecessary and possibly harmful.By the end, you'll understand sunlight as a biological input your body evolved to depend on and the low-cost, practical steps you can take to get more of it.FULL SHOW NOTES HERE: https://l1nk.dev/bjuu235 Sponsor: Shadowmap  https://app.shadowmap.org/?ref=jonathan&discount=JONATHANJ Code: JONATHANJ   Sponsor: Ra Opticshttps://www.raoptics.com/JONATHANJ Code: JONATHANJ About this guest:Academic Profile: https://profiles.ucl.ac.uk/7465 Google Scholar: https://scholar.google.com/citations?user=UYlObKkAAAAJ&hl=en LinkedIn: https://www.linkedin.com/in/glen-jeffery-441a2b1b/ Timestamps:00:16 Intro02:46 Dr. Glen Jeffery03:14 Love for Science, Undergraduate04:24 Tiina Karu, Photobiomodulation Origins, Mechanisms 06:14 Mechanisms, Cytochrome C Oxydase, Nanowater, Electron Flow10:56 Cytochrome C Oxydase, Extra-Pineal Melatonin, Oxidative Stress12:45 Gerald Pollack, Exclusion Zone (EZ) Water13:45 Red/IR Light Passes Through the Human Body; Optics18:09 Red Light On Fruit Flies; Lifespan, ATP Production21:15 Human Epidemiology; Sunlight, Lifespan, All-Cause Mortality22:35 Sponsor: Shadowmap23:30 Features and Benefits of Shadow Map25:02 Incandescents, lifespan, and more25:02 Incandescent Light Produces the Oldest Flies; Broad Band IR on Lifespan25:48 Incandescent Light Bulbs, Vision 28:19 Evolutionarily Conserved Mitochondria29:03 Long-Wavelength Light & Blood Glucose; Mitochondria32:50 Unpublished CGM Data; Long-Wavelength Light & Blood Glucose36:57 Are Red Light Panels Harmful?; Light Intensities, Precautions, Mitigations43:56 Why Do We See Beneficial Effects From Long-Wavelength Therapy? 46:43 Short-Wavelength Blue Light, Mitochondria, Mechanism49:08 The Built Environment, Actionable Steps 52:24 Sponsor: Ra Optics54:24 Flicker55:24 Retinal Health, Blue Light, Red/IR Light59:09 Clinical Trial for Mitochondrial Disease; Ptosis, Red Light01:02:31 Biophotons, Mitochondrial Communication, Red/NIR on Biophotons 01:13:54 Support, YouTube, Spotify & Apple Follow, Reviews & Feedback, Social Media, Substack Newsletter

Host Dr. Jay Sridhar welcomes ophthalmology program directors Drs. Chris Alabiad and Alice Zhang to discuss the ophthalmology residency match, the rising pool of reapplicants to the field, and how to mentor and advise students pursuing reapplication. For all episodes or to claim CME credit for selected episodes, visit www.aao.org/podcasts.

Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we delve into a series of impactful developments shaping the future of medical innovation and patient care. The landscape of pharmaceutical and biotech industries is currently experiencing notable shifts driven by scientific advancements, regulatory updates, and strategic collaborations. One of the more controversial events involves the retraction of a high-profile study in Nature Medicine. This study initially suggested that the timing of PD-1 inhibitor administration had significant impacts on survival rates for non-small cell lung cancer patients. Early-day administration was linked to improved outcomes compared to later in the day. However, after a four-month investigation, concerns over methodological validity led to its retraction. This incident serves as a stark reminder of the necessity for rigorous peer review and transparency in clinical research, which are essential for influencing treatment protocols effectively. In industry news, Eli Lilly has entered into a major $1.9 billion partnership with Abbisko Therapeutics to harness Abbisko's drug discovery capabilities, particularly in oncology. This collaboration highlights an increasing trend where Western pharmaceutical companies team up with Asian biotech firms to accelerate drug development and tap into innovative therapeutic platforms. Eli Lilly is also recalibrating its strategy for launching its oral obesity treatment, Foundayo, in Europe, as it navigates the complexities introduced by the Most Favored Nation pricing agreement with the U.S. This underscores a broader challenge within the industry: balancing pricing regulations with expanding access through digital health channels like telehealth. ADC Therapeutics is taking steps to address safety concerns surrounding its antibody-drug conjugate, Zynlonta, by reducing its workforce by 17%. This strategic realignment demonstrates the delicate balance companies must maintain between advancing promising therapies and ensuring patient safety through vigilant clinical oversight. On the regulatory front, Incyte's decision to drop its lawsuit against CMS over drug classification issues involving its JAK inhibitor Opzelura highlights ongoing negotiations between pharmaceutical companies and regulatory bodies. These classifications have direct implications for market access and reimbursement strategies. Shifting focus to infrastructure, Advancell's move to establish its U.S. headquarters near Boston for radiopharmaceutical production underscores an emphasis on localizing drug manufacturing facilities to enhance supply chain resilience. This decision aligns with broader efforts to support domestic clinical trials for innovative therapies targeting prostate cancer. In terms of technological innovation, Novartis has invested $105 million upfront in Antares Therapeutics to target historically undruggable cancer proteins through small molecule development. This move reflects an industry-wide push towards exploiting cutting-edge technologies like AI-driven drug discovery to meet unmet medical needs in oncology. Precision medicine continues to gain traction, exemplified by Abbott's partnership with AlzPath to develop blood-based diagnostic tests for Alzheimer's disease. Collaborations such as these are pivotal in enhancing early diagnosis and personalized treatment approaches for neurodegenerative disorders. Meanwhile, the industry's financial dynamics continue to evolve with significant fundraising activities. Serapha Bio's public debut through a reverse merger with Boundless Bio raised $230 million, highlighting a growing trend of utilizing reverse mergers as a pathway to public markets. This financial boost comes alongside their licensing of a gene editing technology from China, underscoring the global nature of biotech collaborations. In oncology, Eli Lilly's extended partnership with Abbisko Therapeutics underscores the ongoing commitment to precision medicine, aiming to harness small molecule innovations targeting specific cancer pathways. Concurrently, the European Medicines Agency approved Astellas' Padcev combined with Merck & Co.'s Keytruda for muscle-invasive bladder cancer treatment based on promising Phase 3 results. Ophthalmology research is also seeing substantial investment with Ollin Biosciences raising $330 million in Series B funding aimed at developing therapies that challenge existing treatments like Vabysmo for eye diseases. Such investments indicate strong confidence in novel therapies that could redefine standards in treating conditions like wet age-related macular degeneration. In conclusion, these developments reflect a vibrant biotech and pharma landscape characterized by strategic partnerships, innovative financing mechanisms, and regulatory milestones that collectively drive forward scientific progress and enhance therapeutic options available worldwide. As these sectors continue to evolve, integrating cutting-edge technologies like gene editing and precision oncology will be pivotal in shaping healthcare delivery's future trajectory while improving patient outcomes globally.Support the show

This CEO Wants To Help Your Nerves Heal Faster. Meet Adam Rogers CEO NervGen – NGEN GuestAdam Rogers, MD, Chair, President & Chief Executive Officer at NervGenAdam's BIO: Adam H. Rogers, MD, is the President and Chief Executive Officer of NervGen Pharma and has served as Chairman of the Company's Board of Directors since July 2025. Dr. Rogers has more than fifteen years of experience advancing novel therapies for diseases with significant unmet medical need. He is the Principal of Boston-based PFP Biosciences Holdings and previously co-founded Hemera Biosciences in 2010, a clinical-stage biotechnology company developing a one-time investigational gene therapy administered via outpatient intravitreal injection to preserve vision in patients with geographic atrophy, a late-stage and severe form of age-related macular degeneration. He served as Hemera's Chief Executive Officer from 2017 until December 2020, when the rights to its lead program were acquired by Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson. Earlier in his career, Dr. Rogers served as an Assistant Professor of Ophthalmology at the New England Eye Center at Tufts Medical Center and has authored numerous peer-reviewed publications. Dr. Rogers is a board-certified ophthalmologist specializing in diseases and surgery of the retina and vitreous and holds an MD from Emory University School of Medicine.Company Bio NervGen Pharma (NASDAQ: NGEN) is a clinical-stage biopharmaceutical company developing first-in-class neuroreparative therapeutics for spinal cord injury (SCI) and other neurotraumatic and neurologic conditions. The Company's mission is to transform the lives of individuals living with SCI by enabling the nervous system to repair itself. NervGen's lead therapeutic candidate, NVG-291, is a subcutaneously administered, neuroreparative peptide designed to target the inhibitory CSPG-PTPσ pathway. NVG-291 is the first pharmacologic candidate to improve function, independence, and quality of life in chronic tetraplegia, as demonstrated in the Phase 1b/2a CONNECT SCI study. NVG-291 has received Fast Track designation from the FDA and Orphan Drug designation from the European Medicines Agency for the treatment of SCI. Through NVG-291 and the Company's next-generation candidate, NVG-300, NervGen is pursuing a pharmacologic approach to transform the treatment paradigm for neurotraumatic and neurologic conditions with significant unmet medical need. For more information, visit www.nervgen.com and follow NervGen on X and LinkedIn.

Humans have five senses, but for most of us, sight dominates. That's why vision problems are so distressing. Have you been dealing with difficulties with your eyes? During this broadcast episode, our guest expert is ready to answer your questions about vision problems. At The People's Pharmacy, we strive to bring you up to date, rigorously researched insights and conversations about health, medicine, wellness and health policies and health systems. While these conversations intend to offer insight and perspective, the content is provided solely for informational and educational purposes. Please consult your healthcare provider before making any changes to your medical care or treatment. How You Can Listen You could listen through your local public radio station or get the live stream at 7 am EST on Saturday, June 20, 2026, through your computer or smart phone (wunc.org).  Here is a link so you can find which stations carry our broadcast. If you can't listen to the broadcast, you may wish to hear the podcast later. You can subscribe through your favorite podcast provider, download the mp3 using the link at the bottom of the page, or listen to the stream on this post starting on June 22, 2026. On this episode, we will be taking calls from listeners. You can ask your question ahead of time by emailing radio@PeoplesPharmacy.com. Or call 888-472-3366 directly between 7 and 8 am EDT on Saturday, June 20, 2026. Are More People Nearsighted? Myopia, the technical term for nearsightedness, is increasing at a rapid rate. Globally, 23 percent of the world’s population had myopia in 2000. By 2020, that rate had risen to 34 percent. Some experts estimate that it could reach 50 percent by 2050. Rates among children and adolescents are even higher in some places, reaching 70 percent among East Asians and an alarming 86 percent among Singaporean Chinese youth 15 and under (British Journal of Ophthalmology, July 2016).  Why are so many people, including young people, myopic? Are there implications beyond a need for corrective lenses (glasses or contacts)? Can we reverse this trend by limiting screen time or encouraging more time outdoors? Are there treatments that can help children and adolescents improve their vision? Which Vision Specialist Should You See? Eyes are complicated, and caring for vision problems has become increasingly specialized and technically sophisticated. As a result, ophthalmologists (eye doctors) now often treat just one part of the eye, such as the retina or the cornea. Some surgeons specialize in removing cataracts. Others, like Dr. Sharon Fekrat, are expert in retinal surgery. There are also pediatric ophthalmologists who treat children. In addition, some people need to consult a neuro-ophthalmologist or someone who specializes in inherited retinal degenerations, uveitis or ocular oncology. How can you determine which type of eye doctor you should see to address your particular problem most effectively? What Is in a Complete Eye Examination? Dr. Fekrat will describe the elements of a complete eye examination. Why is each one included? What further steps are needed if trouble is detected? This will give you an idea of how vision problems are assessed and where to turn for treatment. Managing Dry Eyes One of the most common complaints is dry eyes. This condition is uncomfortable as well as common, affecting up to half of adults in the US. What are the causes? Are there treatments? People often use eye drops to alleviate the discomfort. Which ones work best? What can a person do if they have severe dry eye problems and are referred to a dry eye specialist with an appointment months in advance? Is it dangerous to postpone dry eye care? What to Do About Blepharitis When the problem is more the eyelid than the eye itself, doctors call it blepharitis. One typical symptom is crust on the lids, which may feel itchy or scratchy. Some people find that applying warm compresses morning and evening is helpful. Others need medication. You may have seen ads for Xdemvy, which is aimed at reducing the population of Demodex mites living in the follicles of the eyelashes. Mites are not the only problem, however. Sometimes bacterial infections are the underlying cause of blepharitis. Rosacea and seborrheic dermatitis that affect skin elsewhere on the face may also show up with the same symptoms.  Topical ivermectin cream has been used off-label on the eyelid margins and may help reduce Demodex mites, but it is not an FDA-approved eye treatment and should only be used under an eye clinician's direction because it is not intended for instillation into the eye. How Will the Doctor Diagnose Glaucoma? Glaucoma is generally understood as a condition in which pressure inside the eye rises and damages the optic nerve. This disease can lead to vision loss. That's why intraocular pressure measurement should always be part of the eye exam. But this simple diagnostic technique alone may be incomplete. We'll ask Dr. Fekrat about additional approaches that might pick up normal-pressure glaucoma. How is it treated? Age-Related Macular Degeneration Deserves Treatment Another of the vision problems that can cause serious impairment is age-related macular degeneration. In this disorder, the central part of the retina, the macula, loses its ability to focus. Patients may notice that the central part of the vision is blurry, and it may be harder to see under low light conditions. Ophthalmologists now have a range of medications to inject to slow the progression of macular degeneration. Dr. Fekrat can describe the difference between “dry” and “wet” macular degeneration and the drugs used to treat them. What Other Vision Problems Are Troubling You? This is a chance to ask questions and get answers about vision problems from an expert. You can send email to radio@PeoplesPharmacy.com or call in your questions to 888-472-3366 between 7 and 8 am EDT on Saturday, June 20, 2026. This Week’s Guest Sharon Fekrat, MD, is a retina surgeon at the Duke Eye Center of the Duke Health Integrated Practice and vice chair of faculty affairs and the Robert Machemer MD Distinguished Professor of Ophthalmology at the Duke University School of Medicine. She is associate chief of staff at the Durham VA Healthcare System and past interim chief of surgery there. She is Director of Duke iMIND Research Group and Chief Editor of the book All About Your Eyes as well as the Digital Journal of Case Reports of Ophthalmology. Dr. Fekrat is past President of the NC Society of Eye Physicians and Surgeons. The People's Pharmacy is reader supported. When you buy through links in this post, we may earn a small affiliate commission (at no cost to you). Sharon Fekrat, MD, FASRS, Duke Eye Center Listen to the Podcast The podcast of this program will be available Monday, June 22, 2026, after broadcast on June 20. You can stream the show from this site and download the podcast for free. Download the mp3, or listen to the podcast on Apple Podcasts or Spotify.

I just watched The Backrooms and now I can't stop thinking about hospital liminal spaces. The basement. The pathology lab. The OR at 2 AM when you're going in for an open globe. We start there. Then a great Spotify question pulls me into ophthalmology boards, what the written test is like, the oral exam I took inside an examiner's actual hotel room (with their luggage in the corner) during a hotel workers' strike in San Francisco, the $2,000 fee, and why the whole recertification industry feels like a money grab. Also a quick rant about why physicians start their careers $400K in the hole and a decade behind everyone else. The main event is a tale of two health systems. You already know PeaceHealth in Eugene, where the emergency physicians fought back, used Oregon's corporate practice of medicine law, and took it to court. Now meet Valley Health in Virginia's Shenandoah Valley, where CEO Mark Nance just cancelled the contract for EMBER (Emergency Medicine of Blue Ridge) and handed it to SCP Healthm a private equity outfit backed by Canada's Onex Corporation. Same Apollo MD playbook. Same damage. But Virginia has no corporate practice of medicine law, no physician union, and no nurses' union, and Valley Health is flush with cash while blaming Medicaid cuts. I'm fed up, and I'm going to keep making this content as long as people keep sending it to me. Takeaways: Valley Health in Virginia's Shenandoah Valley cancelled its 20-plus-year contract with EMBER (Emergency Medicine of Blue Ridge) and handed it to SCP Health, a private equity-backed corporation owned by Canada's Onex Corporation, mirroring the Apollo MD/PeaceHealth situation in Eugene Despite blaming Medicaid cuts from the "Big Beautiful Bill," Valley Health holds over $1 billion in assets, $700 million in cash reserves, and reported $100 million in net profit in 2024 and continues to build new facilities Valley Health has also forced out Front Royal Family Practice under CEO Mark Nance, revealing a broader pattern of consolidating independent groups and eliminating physician autonomy Virginia has no corporate practice of medicine law, no physician union, and no nurses' union, leaving healthcare workers without the legal and organizational protections that allowed the Eugene physicians to fight back successfully Ophthalmology board recertification, board exam fees, and roughly $400K in training debt mean most physicians don't start meaningful earnings until age 31 or later, a financial reality often missing from broader debates about physician pay To Get Tickets to Wife & Death: You can visit Glaucomflecken.com/live  We want to hear YOUR stories (and medical puns)! Shoot us an email and say hi! knockknockhi@human-content.com Can't get enough of us? Shucks. You can support the show on Patreon for early episode access, exclusive bonus shows, livestream hangouts, and much more! –⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ http://www.patreon.com/glaucomflecken⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠  Also, be sure to check out the newsletter: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://glaucomflecken.com/glauc-to-me/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ If you are interested in buying a book from one of our guests, check them all out here: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.amazon.com/shop/dr.glaucomflecken⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ If you want more information on models I use: Anatomy Warehouse provides for the best, crafting custom anatomical products, medical simulation kits and presentation models that create a lasting educational impact.  For more information go to Anatomy Warehouse DOT com. Link: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://anatomywarehouse.com/?aff=14⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Plus for 15% off use code: Glaucomflecken15 -- A friendly reminder from the G's and Tarsus: If you want to learn more about Demodex Blepharitis, making an appointment with your eye doctor for an eyelid exam can help you know for sure. Visit ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠http://www.EyelidCheck.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ for more information.  Produced by⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Human Content⁠ Learn more about your ad choices. Visit megaphone.fm/adchoices

Host: Priya Vakharia, MD Guest: Andrew Moshfeghi, MD The SOL-1 Phase 3 superiority trial compared the efficacy and safety of the investigational product OTX-TKI (axitinib intravitreal hydrogel) with aflibercept 2 mg. The primary endpoint was proportion of subjects who maintained visual acuity, defined as

In this episode, we discuss the promising results of intravitreal gene therapy for neovascular AMD with 4D-150 with Dr. Arshad Khanani of Sierra Eye Associates and Clinical Professor of Ophthalmology at the University of Nevada Medical School, Reno.

Send us Fan MailCataract surgery is one of the most common operations in the U.S. While most of us associate cataracts with older adults, anyone can get cataracts for a number of reasons. Our guest for this episode is Catherine Reppa, M.D., ophthalmologist with Texas Tech Physicians and associate professor in the School of Medicine's Department of Ophthalmology and Visual Sciences. Dr. Reppa defines for us what a cataract is, goes over symptoms and treatments are available; tell us what we can expect from cataract surgery and the risks involved, and what we can do to protect our eyes and our overall health. 

In this episode of The Retina Channel Podcast, Dr. Keyvan Koushan sits down with renowned retina specialist John Kitchens to discuss the rapidly evolving role of artificial intelligence in ophthalmology and medicine. Dr. Kitchens shares his practical experience using AI platforms such as ChatGPT, Claude, Gemini, and Perplexity, offering insights into how these tools can enhance clinical practice, education, research, communication, and everyday productivity. The conversation explores both the opportunities and limitations of AI, provides real-world examples of its use in ophthalmology, and offers a thoughtful look at how physicians can prepare for a future increasingly shaped by intelligent technologies. Whether you're an AI enthusiast or just beginning to explore these tools, this episode offers a practical and engaging perspective on one of the most important technological shifts in modern medicine.

Professor of ophthalmology Daniel Palanker is a physicist who has combined his skills in optics and electronics to create PRIMA – the Photovoltaic Retinal Implant. Inserted beneath the retina, it restores vision to patients blinded by retinal degeneration, allowing them to read and write – and with the next-generation software, to recognize faces. PRIMA's photovoltaic pixels act like tiny solar panels, converting light into electricity to stimulate the remaining retinal neurons. Better yet, the growing field of brain-computer interfaces may have implications beyond ophthalmology. “Unlike medicine, where the road ends with curing a disease or restoring lost function, the prospects for brain-machine interfaces may be infinite,” Palanker tells host Russ Altman on this episode of Stanford Engineering's The Future of Everything podcast. Have a question for Russ? Send it our way in writing or via voice memo, and it might be featured on an upcoming episode. Please introduce yourself, let us know where you're listening from, and share your question. You can send questions to thefutureofeverything@stanford.edu. Episode Reference Links: Stanford Profile: Daniel Palanker Connect With Us: Episode Transcripts >>> The Future of Everything Website Connect with Russ >>> Threads / Bluesky / Mastodon Connect with School of Engineering >>> Twitter/X / Instagram / LinkedIn / Facebook Chapters: (00:00:00) Introduction Russ Altman introduces guest Daniel Palanker, a professor of ophthalmology and electrical engineering at Stanford University. (00:03:17) Path into Ophthalmology How Palanker's background in physics and optics led him to vision research. (00:04:33) How Vision Works A primer on the eye, retina, photoreceptors, and the neural code of sight. (00:08:50) Retinal Degeneration How diseases like macular degeneration and inherited retinal disorders damage vision. (00:13:18) The PRIMA Implant How a photovoltaic retinal implant converts light into electrical stimulation. (00:15:05) Augmented Reality Glasses How camera-equipped glasses amplify and project images to power the implant. (00:17:42) From Reading to Face Recognition Why grayscale vision is the next step toward recognizing faces. (00:20:18) Implanting the Device How the wireless chip is placed under the retina and powered by light. (00:21:45) Replaceable Vision Technology How future generations of implants could be swapped in for higher resolution. (00:22:28) Limits of Resolution Why geometry and proximity to neurons determine how small pixels can get. (00:24:00) Moving to 3D Electrodes How pillar-shaped electrodes help neurons move closer to the implant. (00:26:28) Clinical Path Forward The status of European trials, FDA discussions, and future patient access. (00:28:10) Safety and Real-World Use What trials reveal about surgical risks, durability, and patients using implants at home. (00:30:11) Future In a Minute Rapid-fire Q&A: neural coding, brain-machine interfaces, and restoring vision. Connect With Us:Episode Transcripts >>> The Future of Everything WebsiteConnect with Russ >>> Threads / Bluesky / MastodonConnect with School of Engineering >>>Twitter/X / Instagram / LinkedIn / Facebook Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

With ophthalmology being the busiest NHS outpatient specialty, with around 9.7 million appointments in England in 2024, the Royal College of Ophthalmology's new president, Mohamed Elalfy undoubtedly has a busy three years in the role ahead. Mohamed speaks with In Touch about his plans for the College and about issues of concern to eye health and care patients, including the issue of long waiting times for appointments and potential new treatments for eye diseases.Caroline Mackenzie contacted In Touch with concerns over whether or not her young grandson should learn braille. She has been wondering whether or not it will be worth his time, given how quickly assistive technology is evolving. Does braille have a future in the face of evolving technologies? To share your thoughts on this, please email intouch@bbc.co.uk or leave a voice message on 0161 836 1338.Presenter: Peter White Producer: Beth Hemmings Production Coordinator: Helen Surtees Website image description: Peter White sits smiling in the centre of the image, wearing a dark green jumper. Above Peter's head is the BBC logo (three individual white squares house each of the three letters). Bottom centre and overlaying the image are the words "In Touch"; and the Radio 4 logo (the word Radio in a bold white font, with the number 4 inside a white circle). The background is a bright mid-blue with two rectangles angled diagonally to the right. Both are behind Peter, one of a darker blue and the other is a lighter blue.

Engineering a solution is one thing; making it work in a high-stakes clinical environment is another. This panel discussion features the minds who build the tech and the hands that use it. Leading bioengineers and frontline clinicians from NYU, NYU Abu Dhabi, the University of Michigan and the University of Maine deconstruct the challenges of medical device innovation. The topics include glaucoma and other chronic diseases such as metabolic, cardiovascular, and neurologic diseases. The discussion also touches on AI, robotics, and wearable technology to improve patient care. Panel Members Andreas Hielscher, Professor of of Biomedical Engineering, NYU Tandon School of Engineering Shy Shoham, Professor of Neuroscience and Ophthalmology, NYU School of Medicine and Tech4Health Giovanna Guidoboni, Professor of Electrical and Computer Engineering and Dean of Engineering and Computing, University of Maine Manjool Shah, Clinical Associate Professor of Ophthalmology and Visual Sciences and Associate Chair of Innovation, University of Michigan Sefy Paulose Joshi, Assistant Professor of Ophthalmology, NYU Langone Health Moderated by Yong-Ak (Rafael) Song, Professor of Mechanical Engineering and Bioengineering and 19 Washington Square North Faculty Fellow, NYUAD

We discuss long term results of faricimab treatment of DME, with the first author of the Ophthalmology article on the results of Rhone-X trial, Dr. Veeral Sheth, Director of Clinical Research at University Retina in Chicago.

Dr. Drew Carey interviews Dr. Avner Hostovsky on his study evaluating the diagnostic yield of a structured systemic workup in patients presenting with acute visual symptoms who were diagnosed with isolated paracentral acute middle maculopathy (PAMM). From his Ophthalmology article, "High Yield of Systemic Workup in Patients with Acute Isolated Paracentral Acute Middle Maculopathy." Hostovsky A, Peled I, Katz G, et al. High Yield of Systemic Workup in Patients with Acute Isolated Paracentral Acute Middle Maculopathy. Ophthalmology, 2025; 133, 499-505.

Purti Kanodia Talks Real-World AI Applications. On this episode of OWA Talks, Purti shares a practical, no-hype approach to building AI fluency. Join us as we get beyond the ‘theory' and talk implementation. If you're curious about AI but overwhelmed, this one's for you.About the guest:Purti Kanodia is a fractional AI transformation leader and founder of Clarity Prompts, an AI consulting firm and weekly newsletter that helps executives and senior leaders build AI fluency and lead practical, responsible AI adoption across their organizations.With nearly two decades of experience across optical retail, employer healthcare, management consulting, and biopharma, Purti has worked with companies including National Vision, Crossover Health, Slalom Consulting, and Genentech, always at the intersection of technology, business strategy, and human change. At National Vision, she led the launch of Toku BioAge, the first AI-based retinal imaging wellness product in US optical retail. Earlier at Slalom Consulting, she spent two years in Ophthalmology designing product strategy for AI/ML clinical decision support tools.What sets Purti apart is her whole-picture lens on technology adoption. She starts with the problem, not the technology, and believes that testing without measurement rarely survives the pilot. Getting to real scale means thinking through people, process, and organizational readiness together, not as an afterthought.She has mentored startups through Singularity University Labs, the UCSF Entrepreneurship Center, and HealthTech Capital. Purti holds a Master of Science in Biotechnology from Georgetown University and is based in the San Francisco Bay Area.Like this episode? Please subscribe and share!iTunes | Spotify | Overcast | iHeartRadio | AmazonConnect with the OWA:Website | LinkedIn | Instagram | Facebook

In our latest episode we discuss the results of a novel approach to the treatment of geographic atrophy using Xelafaslatide a Fas inhibitor with Dr. David Zacks, Professor of Ophthalmology at the Kellogg Eye Center at the University of Michigan.

Today, Peggy Burkhard talks with Dr. Amar Kelkar of the Dana-Farber Cancer Institute about the medical side of survivorship after bone marrow, stem cell, or CAR-T transplant. The conversation begins with the important shift from the urgent “save my life” phase to the longer “protect my health” phase. Dr. Kelkar explains that this transition often starts around the 100-day mark, though timing varies by transplant center, geographical region and patient needs. A major theme is the need to restart routine care that may have been paused during transplant. Dental care, dermatology, ophthalmology, and primary care all become important again. Dental visits are especially important because oral graft-versus-host disease (GVHD) can cause dry mouth, irritation, cavities, and other problems. Skin checks matter because transplant can increase the risk of skin cancers. Dr. Kelkar stresses annual dermatology visits, sun protection, SPF 50 or higher, protective clothing, and smart decisions about sun exposure. Fatigue is another central topic. Dr. Kelkar describes post-transplant fatigue as different from normal tiredness. It can feel deep, physical, and mental, and it may last for months or even years. He encourages patients to pace themselves, listen to their bodies, and build activity back slowly. Returning to work also needs to be individualized. Some patients work remotely during treatment, while others may need extended disability or a gradual return. The episode also covers immune recovery and repeat vaccinations. Dr. Kelkar explains that after transplant, the immune system has been reset, and many childhood vaccines need to be repeated. Most programs begin revaccination around six, nine, or 12 months, depending on immune suppression and other factors. He reassures listeners that many patients have fewer vaccine symptoms early on because their immune systems are still rebuilding. Dr. Kelkar also reviews long-term screening and prevention. Survivors need routine cancer screenings, including mammograms, colonoscopies, lung cancer screening when appropriate, skin exams, and monitoring for thyroid or other changes. Metabolic health is also important. Steroids can affect blood sugar, transplant can change body composition, and quick weight loss often includes muscle loss. Nutrition support and exercise programs can help, and Peggy notes that Blood Cancer United offers nutrition services for patients and caregivers. Blood Cancer United's nutrition program provides free one-on-one consultations with oncology dietitians by phone or email. Bone health, hormone changes, sexual health, and early aging are also discussed. Dr. Kelkar explains that steroids, menopause, testosterone changes, vitamin D deficiency, and time indoors can affect bones. Many centers use DEXA scans and vitamin D supplementation. He also encourages patients to bring up sexual health concerns, including menopause symptoms, low testosterone, pain with intercourse, ulcers, or fear about resuming intimacy. The episode closes with practical advice for everyday life. Food restrictions often loosen around 100 days, but patients should reintroduce foods slowly and carefully. Raw foods, alcohol, tobacco, and inhaled smoke should generally be avoided, especially during the first year. Dr. Kelkar also emphasizes mental health support, counseling, and honest conversations with the medical team. Survivorship is a bumpy road, but the goal is to help patients regain control and thrive. Blood Cancer United Nutrition Offerings: https://bloodcancerunited.org/blood-cancer-care/adults/food-nutrition Thanks to this season's sponsors, Incyte and Sanofi. (00:00) Intro (01:16) Moving from acute treatment to survivorship (02:17) Dental, dermatology, ophthalmology, and routine care (05:45) Fatigue after transplant versus normal tiredness (08:35) Pacing yourself and avoiding setbacks (10:26) Returning to work after transplant (12:24) Resetting the immune system and repeat vaccinations (16:07) Secondary malignancy prevention and cancer screenings (18:59) Sun protection and skin cancer prevention (20:23) Metabolic health, blood sugar, and weight management (23:58) Bone health, vitamin D, DEXA scans, and early aging (29:32) Sexual health and hormonal changes (32:43) Everyday living after transplant (36:07) Psychological and cognitive hurdles in survivorship (38:16) Pulmonary function tests and liver monitoring (40:42) Closing thoughts National Bone Marrow Transplant Link - (800) LINK-BMT, or (800) 546-5268.nbmtLINK Website: https://www.nbmtlink.org/Check out our valued nbmtLINK resource books, some for sale, some free as downloadable, https://www.nbmtlink.org/shop/nbmtLINK Facebook Page: https://www.facebook.com/nbmtLINKFollow the nbmtLINK on Instagram! https://www.instagram.com/nbmtlink/The nbmtLINK YouTube Page can be found by clicking here.This content is provided for informational purposes only and is not intended to substitute for professional medical advice, diagnosis, or treatment. It is crucial to consult directly with a qualified healthcare professional regarding any medical conditions, treatment options, or other health concerns.The views and opinions expressed by the speakers are their own and do not necessarily reflect the official policy or position of the nbmtLINK. Unless otherwise stated in an official policy, the nbmtLINK does not endorse any specific treatments, products, or services mentioned by the speakers. Reliance on any information provided is solely at your own risk.The Marrow Masters Podcast is produced by JAG Podcast Productions: https://jagpodcastproductions.com/ Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Implantable collamer lenses, or ICLs, have evolved from a niche alternative for extreme prescriptions into a mainstream refractive option that is increasingly being chosen over LASIK—even for some ideal LASIK candidates. In this episode, we explore what changed: the history of the procedure, how ICL surgery is performed, the real risks and safety considerations, and how the visual outcomes compare with LASIK. We also dive into higher-order aberrations, stability of refraction, regression, and whether ICLs may offer superior quality of vision in certain patients. Refractive surgery expert Dr. Avi Wallerstein joins the podcast. Dr. Avi Wallerstein is the co-founder of Vision Group - https://www.thevisiongroup.com/ Become a supporter of this podcast: https://www.spreaker.com/podcast/blind-spot-the-eye-doctor-s-podcast--5819306/support.

Transforming healthcare delivery in resource-limited contexts around the world calls for compassionate, innovative solutions. Learn how The Luke Commission is bringing healthcare to the most isolated and underserved in Eswatini through a scalable model for advancing health equity.

In our latest episode, we discuss the use of inhibitors of IL-6 in the treatment of retinal disease with Dr. Steven M. Yeh, Stanley M. Truhlsen, Jr. , Chair of Ophthalmology a the University of Nebraska.

This is the first episode on our special mini-series on sleep. Professor Russell Foster is Professor of Circadian Neuroscience, Director of the Nuffield Laboratory of Ophthalmology and the Head of the Sleep and Circadian Neuroscience Institute at the University of Oxford. He is the author of the Sunday Times bestseller 'Life Time'.In this episode, we take a whirlwind tour of how we've developed circadian rhythms and how they orchestrate pretty much every function in our body. We turn the focus onto sleep, of course, and speak about the impact of shift work, what is known about the sleep disruption in mental illness (chicken or egg?!) and much more. You can see more of Prof Foster's research at https://www.scni.ox.ac.uk/Interviewed by Dr. Anya Borissova with Dr. Rosy Blunstone. Dr. Borissova is an academic psychiatry registrar at the South London and Maudsley Trust. Dr. Blunstone is a psychiatry and psychotherapy registrar in London. Check out The Thinking Mind  on Substack: https://substack.com/@thinkingmindpodcastIf you would like to invite Alex to speak at your organisation please email alexcurmitherapy@gmail.com with "Speaking Enquiry" in the subject line.Alex is not currently taking on new psychotherapy clients, if you are interested in working with Alex for focused behaviour change coaching , you can email - alexcurmitherapy@gmail.com with "Coaching" in the subject line. Give feedback here - thinkingmindpodcast@gmail.com Follow us here: Twitter @thinkingmindpod Instagram @thinkingmindpodcast

What is cultural distress? It is a negative response rooted in a cultural conflict where the patient lacks control over their situation. It results in more physiologic effects on the body resulting in allostatic overload. To prevent this, healthcare practitioners must use strategies such as cultural humility to help patients navigate healthcare. Come find the best ways to deliver culturally sensitive care in any setting.

In this episode, we discuss the use of aflibercept 8mg for the management of retinal vein occlusion and the results of the QUASAR study with Dr. Sunir Garg, Co Director of Retina Research at the Wills Eye Hospital and Professor of Ophthalmology at Thomas Jefferson University.

In this episode of Reboot IT, host Dave Coriale, president of DelCor, sits down with Joe Carr, Vice President of Information Technology at the American Academy of Ophthalmology, who shares how “light governance” can encourage experimentation while still protecting member data and intellectual property. They also discuss IT's evolving role as an enabler rather than a gatekeeper, the importance of data hygiene and content management, and why fostering an entrepreneurial mindset matters more than chasing the perfect AI policy. The conversation offers guidance for IT leaders and non-technical staff alike on how to safely and usefully integrate AI into daily work.Themes and Topics:Light AI Governance vs. OverengineeringKeeping AI governance policies short (3–5 pages) and written in plain language.Establishing “rules of the road” instead of rigid, draconian controls.Allowing experimentation while increasing oversight for sensitive data use.IT's Evolving Role: From Gatekeeper to EnablerIT provides secure platforms, guardrails, and integration—not every AI solution.Encouraging staff to explore AI independently within safe environments.“Making the sandbox” so staff can build their own solutions.Multiple AI Tools, One StrategySupporting several leading platforms (Copilot, Claude, OpenAI, Gemini) based on use cases.Focusing on how tools are used, not controlling which tool is used.Ensuring security, legal review, and IP protection across platforms.Data Hygiene and Content Management as AI FoundationsRecognizing that outdated or unmanaged content can undermine AI results.Shifting from document retention to true knowledge management.Designing content and websites so AI can surface accurate, relevant information.Encouraging AI Curiosity Through CultureUsing non-IT staff to demonstrate real-world AI use cases.Hosting lunch-and-learns, showcases, and Teams channels for sharing ideas.Executive support as a key driver of experimentation and adoption.Entrepreneurial Thinking and Mission AlignmentEmbracing experimentation and being willing to fail safely.Using AI to rethink workflows, not just automate existing tasks.Tying AI initiatives back to organizational mission and business goals.

Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. The industry is buzzing with significant shifts driven by scientific advancements, strategic acquisitions, and regulatory changes. A noteworthy transaction is Bayer's $2.4 billion acquisition of Perfuse, aimed at gaining control over an eye disease implant that has shown promising results in phase 2 trials. This acquisition speaks to Bayer's commitment to expanding its ophthalmology portfolio, a field with substantial unmet medical needs due to aging populations. The move highlights how companies are investing heavily in areas expected to see growing patient demand. In the realm of artificial intelligence, Recursion Pharmaceuticals is undergoing a strategic transformation under new leadership. After a decade of AI-driven research without yielding tangible products, the focus is shifting towards translating AI's potential into viable therapeutic solutions. This reflects a broader industry trend where the promise of AI must be balanced with pragmatic strategies to ensure commercial success. Novo Nordisk is making strides with its GLP-1/amylin combo treatment Cagrisema, maintaining its launch plans despite technical setbacks with a single-chamber device design. This demonstrates the company's adaptability in overcoming hurdles to bring innovative diabetes treatments to market, crucial in the competitive landscape of diabetes care. Additionally, Novo Nordisk's obesity treatment Wegovy has posted impressive quarterly revenues of $355 million thanks to strategic pricing and timely market entry ahead of competitors like Eli Lilly in the emerging oral obesity therapy segment. Such success suggests potential redefinition of market dynamics in obesity treatments. GlaxoSmithKline has entered into a $1 billion agreement with China's Siranbio for an oligonucleotide therapy targeting abdominal fat reduction. This partnership highlights GSK's strategic focus on cardiometabolic diseases through nucleic acid-based therapies, which offer high specificity and efficacy. Such therapeutics are becoming increasingly attractive for investment due to their potential impact on diverse health conditions. CellCentric's successful Series D funding round, raising $220 million for its myeloma drug, positions it well for pursuing clinical milestones independently. This signifies a shift towards self-reliant biotech models, illustrating how smaller companies are increasingly able to navigate the drug development landscape without traditional pharma partnerships. Gilead's acquisition of Arcellx for $7.8 billion and its subsequent workforce consolidation reflect ongoing realignments within the CAR-T therapy space. These consolidations indicate strategic prioritization within large biopharmaceutical companies to streamline operations while focusing on promising therapeutic areas like CAR-T cells. In corporate restructuring news, Gilead Sciences announced workforce reductions following its acquisition of Arcellx. While aimed at optimizing operations post-acquisition, it raises concerns about job security amid increasing merger activities within the biotech sector. Avalo's promising phase 2 results in skin disease treatment have renewed interest despite challenges from placebo comparisons. This emphasizes the competitive dynamics and high stakes in dermatological drug development, where even modest efficacy signals can significantly drive market activity. BioCryst's decision to halt its diabetic macular edema program to concentrate on rare diseases exemplifies a strategic pivot towards niche markets with potentially higher returns and less competition. This aligns with broader industry trends emphasizing precision medicine and targeted therapies. Eli Lilly's substantial $4.5 billion investment into its Indiana manufacturing complex underscores a commiSupport the show

In this episode, we talk with ophthalmologist Dr. Jennifer Grin about a practical, high-yield approach to evaluating eye complaints, documenting findings, and knowing when to urgently refer. The conversation covers a breakdown of an “easy eye exam” any clinician can do from starting with visual acuity as the eye's vital sign to realistic expectations for the fundus exam. Dr. Grin reviews warning signs such as sudden vision loss, abnormal pupils, flashes/floaters with a curtain (retinal detachment), and concerning trauma. She also highlights common pitfalls like mislabeling serious diseases like conjunctivitis, missing open globe injuries, and prescribing topical steroids or anesthetics without a clear diagnosis. Feedback or episode ideas email the show at wnlpodcast@copic.comDisclaimer: Information provided in this podcast should not be relied upon for personal, medical, legal, or financial decisions and you should consult an appropriate professional for specific advice that pertains to your situation. Health care providers should exercise their professional judgment in connection with the provision of healthcare services. The information contained in this podcast is not intended to be, nor is it, a substitute for medical diagnosis, treatment, advice, or judgment relative to a patient's specific condition.

Blake Williamson, MD, MPH, and Gary Wörtz, MD, return for a new season of Ophthalmology off the Grid! This season, the hosts dive into the basics of training and education at the most prestigious programs in ophthalmology across the United States. In this episode, they invite Pavlina Kemp, MD, residency program director at the University of Iowa Department of Ophthalmology and Visual Sciences, and Samuel Tadros, MD, a PGY-4 ophthalmology resident, to share a state of the union on ophthalmology residency. They discuss what it takes to stand out during the application and interviewing process and find success in the field.

How accurate is ChatGPT responding to patient questions at a 6th grade reading level vs. a 12th grade reading level? Find out in this episode as Drs. Rukhsana Mirza and Angelo Tanna discuss their Ophthalmology Science article, "Accuracy and Readability of Chat Generative Pre-Trained Transformer-4 Omni in Answering Ophthalmology Patient Questions." Accuracy and Readability of Chat Generative Pre-Trained Transformer-4 Omni in Answering Ophthalmology Patient Questions. Hamzeh, Nikoo et al. Ophthalmology Science, Volume 6, Issue 2. Looking for ways to give back? By becoming an EyeCare America volunteer, you could help provide eye care to those in your community most in need, from the comfort of your own office. EyeCare America, established by the American Academy of Ophthalmology in 1985 as the first public service program for eye care, connects uninsured and underinsured patients 18 and over in need of medical eye exams with local ophthalmologists. Visit eyecareamerica.org for more info.

In this episode, Dagny Zhu, MD, speaks with Christina Y. Weng, MD, MBA, FASRS, about women in leadership roles as well as challenges and gender disparities that still exist in health care today. We'd love to hear from you! Send your comments/questions to podcast@healio.com. Follow us on Twitter @Healio_OSN. Mend the Gap would also like to give you the chance to nominate yourself or a colleague for a travel grant! To enter, simply email us at podcast@healio.com! ·        Welcome to this episode 0:11 ·        Introducing Christina Y. Weng, MD, MBA, FASRS 0:22 ·        Tell us about your tenure with Women in Ophthalmology (WIO) 2:20 ·        WIO has seen so much growth. How many members does WIO have? 3:48 ·        Reaching parity in ophthalmology 7:20 ·        Existing gender disparities 8:26 ·        Gender disparity literature 12:48 ·        How did you find mentors, and what challenges did you face in surgical retina? 14:33 ·        How do you think training programs have changed for women? 20:07 ·        How do you balance your life outside of work? 26:28 ·        What advice would you give to others who want to follow your path? 29:00 ·        Thank you! 32:00 Dagny Zhu, MD, is a cornea, cataract and refractive surgeon and medical director and partner at NVISION Eye Centers in Rowland Heights, California. She can be reached on X @DZEyeMD. Christina Y. Weng, MD, MBA, FASRS, is an ophthalmologist and tenured professor at Baylor College of Medicine in Houston.

In this SRNA "Ask the Expert" episode moderated by Krissy Dilger, Dr. John Chen of the Mayo Clinic answered audience questions about MOG antibody disease (MOGAD). He discussed diagnosis and the importance of titers and live cell-based assays given possible false positives [00:02:42]. Dr. Chen reviewed acute management with early high-dose steroids, prolonged tapers, and escalation to plasma exchange for severe or steroid-refractory attacks, as well as evolving long-term options including IVIG/subcutaneous IG and IL-6 blockade [00:04:14]. Audience questions covered relapse prediction, vision recovery timelines, fatigue, pregnancy, heredity, symptom interpretation, and whether to stop immunotherapy when antibodies become undetectable [00:12:13]. Finally, Dr. Chen described current and upcoming research, including a trial that is currently enrolling participants, and future prospects for optic nerve regeneration while cautioning against unproven stem cell clinics [00:41:37].John J. Chen, MD, PhD attended the University of Virginia for his undergraduate and combined MD/PhD degrees and completed his Ophthalmology residency and Neuro-Ophthalmology fellowship training at the University of Iowa. He then took a position at the Mayo Clinic in 2014 where he specializes in Neuro-Ophthalmology. Currently, he serves as a Consultant and Professor of Ophthalmology and Neurology, and Neuro-Ophthalmology Fellowship Director at the Mayo Clinic. Among Dr. Chen's awards and honors are the AAO Senior Achievement Award, Top Doctors in Minnesota, the Heed Fellowship, Real World Ophthalmology Inspiring Academic Leader Award, Ophthalmology Teacher of the Year Award four times leading to induction to the Educators Hall of Fame, and the Mayo Clinic Distinguished Educator Award – awarded to the top educator at Mayo Clinic in Rochester. He is an Associate Editor for Ophthalmology and the Journal of Neuro-Ophthalmology, has authored more than 250 peer-reviewed publications, and focuses his research on ophthalmic imaging, idiopathic intracranial hypertension, and optic neuritis, particularly NMOSD and MOG antibody–associated disease.00:00 Welcome and Introductions01:08 What Is MOGAD?02:42 Causes and Triggers03:23 How MOGAD Is Diagnosed04:14 Acute Attack Treatments06:35 Steroid Side Effects08:13 Testing During Treatment09:09 Long Term Therapies12:13 Interpreting MOG Positivity16:51 Eye Symptoms and Vision Fluctuations20:12 Antibody Titers and Severity21:19 Relapse Risk After First Attack23:09 Seizures and Encephalitis24:17 Vision Recovery After Optic Neuritis25:13 Acute Treatment Window25:57 Hereditary Risk Questions26:35 Stopping Azathioprine Safely29:56 Managing Post Attack Pain30:16 Steroids IVIG and Plasma Exchange32:08 Infections as Triggers33:01 Retesting MOG Antibodies35:01 Fatigue and Workup36:23 Prognosis and Life Expectancy37:45 Tinnitus and Brain Pressure39:05 Pediatric and Pregnancy Concerns41:37 Trials and Future Regeneration46:05 Research Resources and Wrap Up

  This episode of WarDocs features Air Force Lieutenant Colonel, Dr. Charisma Evangelista, the Air Force's leading voice on refractive surgery and an expert in ocular trauma. The conversation begins with her upbringing in the Philippines and her unique path to military medicine, driven by a desire for service and the supportive, collaborative culture she found at the Uniformed Services University. Dr. Evangelista explains her transition from a prospective general surgeon to an ophthalmologist, highlighting the precision of microscopic surgery and the profound impact of sight restoration. She provides a detailed look at the "shield and ship" protocol for managing ruptured globes in combat environments, emphasizing the critical importance of preventing further injury at the point of care.    Dr. Evangelista also shares her experiences as the sole ophthalmologist deployed to Bagram, Afghanistan, where she managed severe, multi-system trauma cases while navigating limited resources. A pivotal moment in the interview occurs when she describes her own experience as a patient; she suffered a retinal detachment while performing surgery, an event that deepened her empathy for those facing vision loss and shaped her leadership style. Currently serving as the Refractive Surgery Consultant to the Air Force Surgeon General, she discusses the technological advancements in corneal collagen cross-linking and refractive standards that maintain pilot and warfighter readiness.    The episode concludes with her leadership philosophy of trust, empathy, and perseverance, alongside her advice for the next generation of military physicians. This comprehensive discussion highlights the technical expertise, emotional resilience, and deep compassion required to protect the vision of the American warfighter, offering listeners an inspiring look at the intersection of high-stakes surgery and humanitarian service. Chapters   (00:00-01:11) Introduction of Lt Col Charisma Evangelista, MD (01:12-05:13) Foundations in Medicine and the Choice of Ophthalmology (05:14-09:32) Specialized Training and Combat Deployment to Afghanistan (09:33-17:00) Ocular Trauma Protocols and Innovations in Refractive Surgery (17:01-22:35) Personal Resilience as a Patient and Leadership Philosophy (22:36-27:10) Advice for Future Medics and Defining a Military Hero Chapter Summaries   (00:00-01:11) Introduction of Lt Col Charisma Evangelista, MD: The episode opens with a tribute to the delicate nature of eye surgery in combat. Host Dr. Doug Soderdahl introduces Dr. Charisma Evangelista as a deeply compassionate healer and a leading expert in military ophthalmology and refractive surgery standards. (01:12-05:13) Foundations in Medicine and the Choice of Ophthalmology: Dr. Evangelista shares her journey from a small town in the Philippines to the Uniformed Services University, highlighting the family-oriented culture of military medical training. She discusses her transition from general surgery to ophthalmology, sparked by a love for microscopic precision and the collaborative nature of the specialty. (05:14-09:32) Specialized Training and Combat Deployment to Afghanistan: The discussion follows Dr. Evangelista through her prestigious civilian fellowship and her subsequent deployment to Bagram Airfield. She details the challenges of serving as the sole ophthalmologist in a combat theater, managing severe ocular trauma and multi-system injuries with limited resources. (09:33-17:00) Ocular Trauma Protocols and Innovations in Refractive Surgery: This section focuses on the "shield and ship" protocol for point-of-injury care and the rewarding outcomes of sight-restoring surgeries. Dr. Evangelista also explains her role as a consultant for the Air Force Surgeon General, detailing how advancements like corneal collagen cross-linking keep service members mission-ready. (17:01-22:35) Personal Resilience as a Patient and Leadership Philosophy: Dr. Evangelista provides a moving account of her own retinal detachment and the traumatic recovery process that followed. She explains how being a patient informed her leadership at the Department of Defense's largest eye center, prioritizing trust, empathy, and perseverance. (22:36-27:10) Advice for Future Medics and Defining a Military Hero: In the final segment, Dr. Evangelista offers encouragement to pre-med and medical students, emphasizing the unique opportunities for growth in military medicine. She reflects on her "Hero of Military Medicine" recognition and her desire to leave a legacy of inspiration and compassionate service. Take Home Messages Protecting the Ruptured Globe: In cases of severe ocular trauma, the most critical step for non-specialists is the "shield and ship" protocol, which involves placing a hard, protective shield over the eye without applying any pressure to the globe. Preventing additional injury at the point of care is essential for giving specialists the best chance to restore a service member's vision. Refractive Surgery as a Readiness Multiplier: Laser vision correction and specialized treatments for conditions like keratoconus are more than elective procedures; they are essential for warfighter readiness. By reducing dependence on eyeglasses and stabilizing corneal conditions, military ophthalmologists ensure that pilots and ground troops can perform their duties with maximum agility and precision. Empathy through the Patient Experience: True compassion in medicine often stems from understanding the fear and uncertainty of the patient. Experiencing a serious medical crisis personally can transform a surgeon's perspective, allowing them to lead with greater empathy and build deeper trust with those under their care. The Collaborative Power of Military Medicine: The military medical system thrives on a culture that prioritizes collective success over individual competition. This foundation of unit cohesion ensures that physicians work together across specialties to provide the highest standard of care in both domestic hospitals and austere combat environments. Persistence in the Face of Adversity: Success in high-stakes fields like ophthalmology requires the ability to persevere through personal health crises, professional challenges, and the rigors of deployment. Growth and innovation often occur as a direct result of these struggles, making a leader more resilient and effective in their mission to serve.   Episode Keywords Military Medicine, Ophthalmology, Ocular Trauma, Eye Surgery, Refractive Surgery Standards, LASIK, PRK, K-LEX, Corneal Collagen Cross-linking, Keratoconus, Bagram Airfield, Combat Medic Training, Eye Injury Protocols, Shield and Ship, Retinal Detachment, Uniformed Services University, Air Force Surgeon General, Hero of Military Medicine, Surgical Leadership, Medical Humanitarian Missions, WarDocs Podcast, Dr. Charisma Evangelista, Sight Restoration, Combat Surgery, Military Healthcare. Hashtags #MilitaryMedicine, #Ophthalmology, #CombatSurgery, #EyeHealth, #WarDocs, #AirForceMedicine, #RefractiveSurgery, #VeteransHealth   Honoring the Legacy and Preserving the History of Military Medicine The WarDocs Mission is to honor the legacy, preserve the oral history, and showcase career opportunities, unique expeditionary experiences, and achievements of Military Medicine. We foster patriotism and pride in Who we are, What we do, and, most importantly, How we serve Our Patients, the DoD, and Our Nation.   Find out more and join Team WarDocs at https://www.wardocspodcast.com/ Check our list of previous guest episodes at https://www.wardocspodcast.com/our-guests Subscribe and Like our Videos on our YouTube Channel: https://www.youtube.com/@wardocspodcast Listen to the “What We Are For” Episode 47. https://bit.ly/3r87Afm   WarDocs- The Military Medicine Podcast is a Non-Profit, Tax-exempt-501(c)(3) Veteran Run Organization run by volunteers. All donations are tax-deductible and go to honoring and preserving the history, experiences, successes, and lessons learned in Military Medicine. A tax receipt will be sent to you. WARDOCS documents the experiences, contributions, and innovations of all military medicine Services, ranks, and Corps who are affectionately called "Docs" as a sign of respect, trust, and confidence on and off the battlefield,demonstrating dedication to the medical care of fellow comrades in arms.     Follow Us on Social Media Twitter: @wardocspodcast Facebook: WarDocs Podcast Instagram: @wardocspodcast LinkedIn: WarDocs-The Military Medicine Podcast YouTube Channel: https://www.youtube.com/@wardocspodcast

In this episode of Eyeluminaries, John A. Hovanesian, MD, FACS, and Jim Mazzo are live from Hawaiian Eye 2026, with guests Baruch D. Kuppermann, MD, PhD and L. Jay Katz, MD. They discuss everything from their unique career journeys to the current treatments and procedures in eye care. Welcome to Eyeluminaries 00:10 Recap of AAO episode 00:34 Intro of Baruch D. Kuppermann, MD, PhD 01:28 What made you enter retina and how has your career evolved? 03:02 The Gavin Herbert Eye Institute 06:02 What are your other interests? 12:09 Nonprofit work and the Armenian EyeCare Project 13:07 Intro of L. Jay Katz, MD 17:14 How did you get into glaucoma? 18:03 How are things going to evolve in treatment and procedures? 20:28 What was the driving force behind leaving academia and working with Glaukos? 25:01 Tell us a favorite Tom Burns story! 26:44 Thank you! 29:50 Baruch D. Kuppermann, MD, PhD, is the Roger F. Steinert Professor, Chair of the Department of Ophthalmology, and Director of the Gavin Herbert Eye Institute at the University of California, Irvine. L. Jay Katz, MD, is the chief medical officer at Glaukos. We'd love to hear from you! Send your comments/questions to eyeluminaries@healio.com. Follow John Hovanesian on X @DrHovanesian.

The post Do the Eyes Have It? Corticosteroid Use and Stewardship in Ophthalmology appeared first on JDDonline - Journal of Drugs in Dermatology.

The post Do the Eyes Have It? Corticosteroid Use and Stewardship in Ophthalmology appeared first on JDDonline - Journal of Drugs in Dermatology.

Today, I'm putting on my "career counselor" hat to address the latest medical social media drama: a spine surgeon who decided to take a break from clinical practice just six months in to become a full-time content creator. While the internet is full of opinions, I'm sharing why I choose to stay in the game, even when YouTube decides to reclassify my skits and slash my ad revenue. For all you med students and residents watching, I'm breaking down why medicine is the ultimate "safety net" that gives you the freedom to create without the pressure of the algorithm. After the break, we're starting a new series called "Thing I Love, Thing I Hate." I'll tell you why a simple stool in the OR convinced me to become an ophthalmologist and why cataract surgery remains the most rewarding 10 minutes of my day. Then, we'll dive into the "Thing I Hate": Neurotrophic Keratitis. It's a degenerative disease where your eye loses the ability to feel pain, which sounds like a superpower, but is actually a dangerous nightmare that can lead to permanent damage. Takeaways: The Illusion of Digital Freedom: Why relying on "owning" an audience on TikTok or YouTube is a risky bet compared to the stability of a medical degree. The "Sitting Down" Advantage: How a single stool during a med school rotation can change the entire course of your career. The 50+ LASIK Trap: Why you should be wary of "LASIK mills" and why cataract technology can actually do more for older patients than laser surgery. The Danger of Comfortable Eyes: Why a lack of pain during a corneal infection is actually a red flag for a "sensitive" organ like the eye. Cutting-Edge Nerve Repairs: How surgeons are experimenting with transplanting leg nerves into the eye to restore vision and feeling. To Get Tickets to Wife & Death: You can visit Glaucomflecken.com/live  We want to hear YOUR stories (and medical puns)! Shoot us an email and say hi! knockknockhi@human-content.com Can't get enough of us? Shucks. You can support the show on Patreon for early episode access, exclusive bonus shows, livestream hangouts, and much more! –⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ http://www.patreon.com/glaucomflecken⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠  Also, be sure to check out the newsletter: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://glaucomflecken.com/glauc-to-me/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ If you are interested in buying a book from one of our guests, check them all out here: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.amazon.com/shop/dr.glaucomflecken⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ If you want more information on models I use: Anatomy Warehouse provides for the best, crafting custom anatomical products, medical simulation kits and presentation models that create a lasting educational impact.  For more information go to Anatomy Warehouse DOT com. Link: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://anatomywarehouse.com/?aff=14⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Plus for 15% off use code: Glaucomflecken15 -- A friendly reminder from the G's and Tarsus: If you want to learn more about Demodex Blepharitis, making an appointment with your eye doctor for an eyelid exam can help you know for sure. Visit ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠http://www.EyelidCheck.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ for more information.  Produced by⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Human Content⁠ Learn more about your ad choices. Visit megaphone.fm/adchoices

In this episode, Jason M. Raidbard, Executive Administrator of Ophthalmology and Visual Sciences at UChicago Medicine, discusses the impact of upcoming Medicaid policy changes, evolving payer dynamics, and the growing role of AI in care coordination. He also shares leadership advice on mentorship, authenticity, and building meaningful relationships to drive long term success.

We're kicking off season seven with an in-depth look at the wild world of ophthalmology, where scientists are pushing the boundaries of what's possible for vision treatments. In this episode, co-host Danielle Mandikian is joined by guests Deepak Lamba, Director and Distinguished Scientist, Ophthalmology, and Susie Crowell, Senior Director, Project Team Leader, to explore the latest in the field of ophthalmology since our season five episode on eye diseases. Together, they dive into the bizarre biology of how our eyes actually work, unpack how and why eye diseases develop, and discuss how transformative new therapies could one day restore sight. Read the full text transcript at www.gene.com/stories/the-wild-world-of-eyeballs